Doctors have also successfully used tuberculosis bacteria to control bladder cancer that has not invaded the bladder wall. Another experimental approach involves linking tumor-specific antibodies with anticancer drugs. The antibodies, which are synthesized in the laboratory and injected into a person, guide the drugs to cancer cells. Alternatively, other antibodies created in the laboratory can adhere to both the cancer cell and a killer lymphocyte, bringing the two cells together so the killer lymphocyte can destroy the cancer cell. So far, such research hasn't resulted in any widely applicable cancer therapies.
Recent research offers hope for new treatments.
Some of them use pieces of oncogenes, which are important in cell regulation and growth. All rights reserved.